发明名称 |
A Helper-Dependent Adenoviral Gene Therapy Delivery and Expression System |
摘要 |
The present invention relates to gene therapy delivery and expression systems comprising at least one helper-dependent adenoviral vector containing a nucleic acid sequence encoding for proteoglycan 4 (PRG4) or a biologically active fragment thereof. The invention further relates to a pharmaceutical composition comprising a therapeutically effective amount of at least one helper-dependent adenoviral vector containing said nucleic acid sequence encoding for proteoglycan 4 (PRG4), or a homolog thereof from any other species, or a biologically active fragment thereof. The invention also relates to the use of the novel gene therapy delivery and expression system according to the invention for use in the prevention and/or treatment of camptodactyly-arthropathy-coxa vara-pericarditis (CACP), or a musculoskeletal disorder such as a joint disorder or joint disease. |
申请公布号 |
US2015361452(A1) |
申请公布日期 |
2015.12.17 |
申请号 |
US201414763326 |
申请日期 |
2014.01.27 |
申请人 |
BAYLOR COLLEGE OF MEDICINE |
发明人 |
Ruan Zhechao;Guse Kilian;Lee Brendan |
分类号 |
C12N15/86 |
主分类号 |
C12N15/86 |
代理机构 |
|
代理人 |
|
主权项 |
1. A gene therapy delivery and expression system, comprising at least one helper-dependent adenoviral vector containing a nucleic acid sequence encoding for proteoglycan 4 (PRG4) or a biologically active fragment thereof, left and right adenoviral inverted terminal repeats (LITR and RITR}, adenoviral packaging signal sequences and non-viral, non-coding stuffer nucleic acid sequences. |
地址 |
Houston TX US |